Pancreatic Cancer Research

ResearcherNantong UniversityNo recent work listed

Gong Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1857-3670; OpenAlex author ID A5100389826. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 4

  1. β2-adrenergic receptor drives the metastasis and invasion of pancreatic ductal adenocarcinoma through activating Cdc42 signaling pathway. Co-author DOI 10.1007/s10735-022-10076-8↗
  2. Orphan nuclear receptor Nurr1 as a potential novel marker for progression in human pancreatic ductal adenocarcinoma. First author DOI 10.3892/etm.2016.3968↗
  3. β2-adrenergic receptor signaling promotes pancreatic ductal adenocarcinoma (PDAC) progression through facilitating PCBP2-dependent c-myc expression. First author DOI 10.1016/j.canlet.2016.01.026↗
  4. High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC). Co-author DOI 10.1007/s13277-015-3625-6↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guoxiong Zhou · 3 shared papers, 2015–2017 · strength 0.17
  2. Cheng Hang · 1 shared paper, 2022 · strength 0.15
  3. Jianxin Zhu · 1 shared paper, 2022 · strength 0.15
  4. Haifeng Chen · 1 shared paper, 2022 · strength 0.15
  5. Ye Lu · 1 shared paper, 2022 · strength 0.15
  6. Ji Li · 2 shared papers, 2015–2017 · strength 0.12
  7. Chunhua Wan · 2 shared papers, 2015–2016 · strength 0.10
  8. Hongyan Zhu · 1 shared paper, 2017 · strength 0.07
  9. Ying Xiao · 1 shared paper, 2016 · strength 0.05
  10. Aiguo Shen · 1 shared paper, 2016 · strength 0.05
  11. Wei Cao · 1 shared paper, 2016 · strength 0.05
  12. Xiaoling Ding · 1 shared paper, 2016 · strength 0.05
  13. Xiaorong Liu · 1 shared paper, 2015 · strength 0.05
  14. Haifeng Zhang · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.